86 related articles for article (PubMed ID: 3908685)
41. [Interleukin 2 production in patients with thyroid diseases].
Malaĭtsev VV; Bogdanova IM; Shatsova EN
Biull Eksp Biol Med; 1986 May; 101(5):594-6. PubMed ID: 3486682
[TBL] [Abstract][Full Text] [Related]
42. Immune functions in inflammatory bowel and coeliac diseases.
Soppi E; Eskola J; Lehtonen OP; Leino R
APMIS; 1988 Sep; 96(9):850-6. PubMed ID: 3166811
[TBL] [Abstract][Full Text] [Related]
43. Lymphocyte subpopulations, lymphoblast transformation activity, and concanavalin A-induced suppressor activity in patients with ulcerative colitis and Crohn's disease.
Davidsen B; Kristensen E
Scand J Gastroenterol; 1987 Sep; 22(7):785-90. PubMed ID: 2960010
[TBL] [Abstract][Full Text] [Related]
44. A prospective, blind investigation of immunological reactions in chronic inflammatory bowel disease. Suppressor activity and immune capacity.
Davidsen B; Kristensen E
Acta Med Scand; 1986; 219(1):113-24. PubMed ID: 2937257
[TBL] [Abstract][Full Text] [Related]
45. Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease.
Suzuki Y; Saito H; Kasanuki J; Kishimoto T; Tamura Y; Yoshida S
Life Sci; 1990; 47(24):2193-7. PubMed ID: 2266787
[TBL] [Abstract][Full Text] [Related]
46. Inflammatory bowel disease: lymphocytic responses to nonspecific stimulation in vitro.
Aas J; Huizenga A; Newcomer AD; Shorter RG
Scand J Gastroenterol; 1972; 7(4):299-303. PubMed ID: 5048743
[No Abstract] [Full Text] [Related]
47. Peripheral blood mononuclear-cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease.
Ming RH; Atluru D; Spellman CW; Imir T; Goodwin JS; Strickland RG
J Clin Immunol; 1987 Jan; 7(1):59-63. PubMed ID: 3104392
[TBL] [Abstract][Full Text] [Related]
48. Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines.
Aguilera-Montilla N; Pérez-Blas M; Valeri AP; López-Santalla M; Rodríguez-Juan C; Mencía A; Castellano G; Manzano ML; Casis B; Sánchez F; Martín-Villa JM
Scand J Gastroenterol; 2004 Dec; 39(12):1236-42. PubMed ID: 15743001
[TBL] [Abstract][Full Text] [Related]
49. Blood-membrane interaction in hemodialysis leads to increased cytokine production.
Luger A; Kovarik J; Stummvoll HK; Urbanska A; Luger TA
Kidney Int; 1987 Jul; 32(1):84-8. PubMed ID: 3498081
[TBL] [Abstract][Full Text] [Related]
50. Cytokines and inflammatory bowel disease.
Radford-Smith G; Jewell DP
Baillieres Clin Gastroenterol; 1996 Mar; 10(1):151-64. PubMed ID: 8732306
[TBL] [Abstract][Full Text] [Related]
51. Association of an interleukin abnormality with the T cell defect in Hodgkin's disease.
Ford RJ; Tsao J; Kouttab NM; Sahasrabuddhe CG; Mehta SR
Blood; 1984 Aug; 64(2):386-92. PubMed ID: 6611180
[TBL] [Abstract][Full Text] [Related]
52. Pitfalls in cytokine analysis in inflammatory bowel disease.
Fiocchi C; Fukushima K; Strong SA; Ina K
Aliment Pharmacol Ther; 1996; 10 Suppl 2():63-9; discussion 70-1. PubMed ID: 8899103
[TBL] [Abstract][Full Text] [Related]
53. [The cytokine cascade: feature of cytokine action].
Koyasu S
Tanpakushitsu Kakusan Koso; 1987 Dec; 32(13):1564-7. PubMed ID: 3127861
[No Abstract] [Full Text] [Related]
54. [T cell colony formation and interleukin-1,2 productivity in patients with chronic renal failure].
Itagaki N
Nihon Naika Gakkai Zasshi; 1988 Dec; 77(12):1847-51. PubMed ID: 3266941
[No Abstract] [Full Text] [Related]
55. [The interleukin system and the energy enzyme activity in lymphocytes of patients with newly detected pulmonary tuberculosis].
Mishin VIu; Pavliuk AS; Zarechnova NV; Ul'ianova TIu; Ali MO
Probl Tuberk; 1988; (6):55-9. PubMed ID: 3264911
[No Abstract] [Full Text] [Related]
56. Release of interleukin-1 by peripheral blood mononuclear cells in patients with tuberculosis and active inflammation.
Chensue SW; Davey MP; Remick DG; Kunkel SL
Infect Immun; 1986 Apr; 52(1):341-3. PubMed ID: 3485575
[TBL] [Abstract][Full Text] [Related]
57. Production of distinct cytokines by epidermal cells.
Luger TA; Köck A; Danner M; Colot M; Micksche M
Br J Dermatol; 1985 Jul; 113 Suppl 28():145-56. PubMed ID: 3925977
[No Abstract] [Full Text] [Related]
58. Molecular mechanism of interleukin-2-induced mucosal homeostasis.
Mishra J; Waters CM; Kumar N
Am J Physiol Cell Physiol; 2012 Mar; 302(5):C735-47. PubMed ID: 22116305
[TBL] [Abstract][Full Text] [Related]
59. Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients.
Manzano L; Alvarez-Mon M; Vargas JA; Girón JA; Abreu L; Fernández-Corugedo A; Román LI; Albarran F; Durántez A
Gut; 1994 Jul; 35(7):955-60. PubMed ID: 8063224
[TBL] [Abstract][Full Text] [Related]
60. Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.
Hawthorne AB; Hawkey CJ
Drugs; 1989 Aug; 38(2):267-88. PubMed ID: 2670519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
